For decades, lots of American patients have been traveling to “fringe” countries like Turkey, Cuba and Thailand in search of…
VERAXA is developing antibody-based cancer therapies aimed at improving the therapeutic window of existing treatment modalities. Its proprietary BiTAC platform…
Earth Science Tech held its first annual meeting of stockholders, virtually, on August 31, 2026+ The shareholders authorized the Board…
As more Americans become underinsured or uninsured as a result of rising health insurance premiums and the several changes that were passed in…
Researchers across the field, from Duke University to Mayo Clinic, are increasingly focused on restoring damaged cartilage rather than simply…
BioMedWire Editorial Coverage: Today's multiple sclerosis treatments can slow down disease progression, but none of them halt it outright, and none…
Earth Science Tech has made meaningful progress over the last few years, building a business anchored in a conglomerate model,…
For many women, UTIs are something they routinely experience. These usually start as a burning sensation or a sudden urge to…
Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) and may include paid advertising. Investors in…
BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them…